Company profile
Advanced Biological Laboratories (ABL) company profile
Advanced Biological Laboratories (ABL), S.A., is a Medical Data Technology company founded in 2000 as a spin-off from CRP-Santé Luxembourg. ABL took control of TherapyEdge, Inc. in 2004 and in 2013 acquired the rights to all viral hepatitis B & C related assets from EVIVAR MEDICAL, respectively. ABL has a comprehensive suite of healthcare management products, including Nadis®, TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, HepatiC® and the DPM which are used for data and patient management, monitoring and personalized reporting applications. In 2012, some of ABL's products also received CE-marking for IVD use. ABL's products, ViroScore® Suite and DeepChek®, are for..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://www.ablsa.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Revenue range
- $0+
- Founded
- 2000-01-01
Headquarters
- Headquarters
- Ul’ba, East Kazakhstan, Kazakhstan
- Postal code
- L-1835
- Country code
- KZ
- Continent
- Asia